Drug Resistance of Pseudomonas Aeruginosa Based on the Isolation Sites and Types of Gastrointestinal Diseases: An Observational Study

Overview

Journal Fukushima J Med Sci

Specialty General Medicine

Date 2024 Dec 18

PMID 39694500

Authors

Hironori Tsujimoto

Yuji Fujikura

Taka-Aki Hamamoto

Hiroyuki Horiguchi

Risa Takahata

Yusuke Ishibashi

Takao Sugihara

Keita Kouzu

Yujiro Itazaki

Sei-Ichiro Fujishima

Koichi Okamoto

Yoshiki Kajiwara

Susumu Matsukuma

Hideki Ueno

Affiliations

Soon will be listed here.

Abstract

We investigated the drug resistance status of Pseudomonas aeruginosa (P. aeruginosa) focusing on its isolation sites and types of diseases.　Materials and methods: A microbiological laboratory database was searched to identify all clinical cultures positive for P. aeruginosa.　Clinicopathologic features and susceptibility of P. aeruginosa to any antibiotics were evaluated in patients admitted to the division of upper (Upper-GI group) or lower gastrointestinal surgery (Lower-GI group).　In addition, we investigated the susceptibility of P. aeruginosa to any antibiotics based on the isolation site.　Results:P. aeruginosa was frequently detected in the sputum and urine of the Upper-GI and Lower-GI groups, respectively.　Among P. aeruginosa isolates from drain discharge, a significantly higher rate of resistance to imipenem, amikacin, and ciprofloxacin was observed; among P. aeruginosa isolates from wounds, a substantially higher proportion had resistance to imipenem and cefozopran in the Upper-GI group.　However, there was no difference between the two groups in the drug resistance of P. aeruginosa isolated from urine, sputum, blood, and ascites.　P. aeruginosa isolated from sputum showed more resistance to imipenem and ciprofloxacin than those isolated from other sites.　Conclusion: There were significant differences in the drug resistance of P. aeruginosa based on the isolation sites and types of diseases.　.

References

Palacios-Baena Z, Giannella M, Manissero D, Rodriguez-Bano J, Viale P, Lopes S . Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clin Microbiol Infect. 2020; 27(2):228-235. DOI: 10.1016/j.cmi.2020.10.016. View

Haghi F, Zeighami H, Monazami A, Toutouchi F, Nazaralian S, Naderi G . Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections. Microb Pathog. 2017; 115:251-256. DOI: 10.1016/j.micpath.2017.12.052. View

Chang Y, Jeon K, Lee S, Cho Y, Kim Y, Chong Y . The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study. J Korean Med Sci. 2021; 36(41):e251. PMC: 8546312. DOI: 10.3346/jkms.2021.36.e251. View

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

de Oliveira A, Sacillotto G, Neves M, Silva A, Moimaz T, Gandolfi J . Prevalence, outcomes, and predictors of multidrug-resistant nosocomial lower respiratory tract infections among patients in an ICU. J Bras Pneumol. 2023; 49(1):e20220235. PMC: 9970364. DOI: 10.36416/1806-3756/e20220235. View

Livermore D . Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis. 2002; 34(5):634-40. DOI: 10.1086/338782. View

Kunz Coyne A, El Ghali A, Holger D, Rebold N, Rybak M . Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infect Dis Ther. 2022; 11(2):661-682. PMC: 8960490. DOI: 10.1007/s40121-022-00591-2. View

Havens T, Rosen D, Rivera-Spoljaric K . Airway multidrug-resistant organisms in a population of tracheostomy and chronic ventilator-dependent children at a tertiary care pediatric hospital. Pediatr Pulmonol. 2022; 58(1):26-34. DOI: 10.1002/ppul.26152. View

Ichihara M, Ogino T, Fujii M, Haraguchi N, Takahashi H, Miyoshi N . Usefulness of Bacterial Culture of Drainage Fluid for Predicting Surgical Site Infection After Crohn's Disease Surgery. Ann Gastroenterol Surg. 2022; 6(3):375-385. PMC: 9130903. DOI: 10.1002/ags3.12530. View

10.

Abubakar U, Al-Anazi M, Alanazi Z, Rodriguez-Bano J . Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review. J Infect Public Health. 2023; 16(3):320-331. PMC: 9804969. DOI: 10.1016/j.jiph.2022.12.022. View

11.

Tsujimoto H, Takahata R, Nomura S, Kumano I, Matsumoto Y, Yoshida K . Predictive value of pleural and serum interleukin-6 levels for pneumonia and hypo-oxygenations after esophagectomy. J Surg Res. 2012; 182(2):e61-7. DOI: 10.1016/j.jss.2012.11.015. View

12.

Vaez H, Salehi-Abargouei A, Ghalehnoo Z, Khademi F . Multidrug Resistant in Iran: A Systematic Review and Metaanalysis. J Glob Infect Dis. 2018; 10(4):212-217. PMC: 6276320. DOI: 10.4103/jgid.jgid_113_17. View

13.

Blanchard A, Rooney A, Yau Y, Zhang Y, Stapleton P, Horton E . Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment. J Cyst Fibros. 2018; 17(6):723-728. DOI: 10.1016/j.jcf.2018.02.008. View

14.

Vincent J, Sakr Y, Singer M, Martin-Loeches I, Machado F, Marshall J . Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 2020; 323(15):1478-1487. PMC: 7093816. DOI: 10.1001/jama.2020.2717. View